Premium
Nutanix Inc (NTNX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Mr. Tarkan ManerPresident & Chief Commercial Officer | -49,26k | 2,67M | Vente | 52,24 - 55,29 | 55,07k | -47,22% |
| 2026-03-15 | Dr. Rajiv RamaswamiCEO & Director | 27,00k | 0,00 | Derivative Exercise and Retained Stock | - | 574,88k | 4,93% |
| 2026-03-15 | Dr. Rajiv RamaswamiCEO & Director | -23,43k | 920,49k | Derivative Exercise and Sale | 39,29 | 574,88k | - |
| 2026-03-15 | Mr. Tarkan ManerPresident & Chief Commercial Officer | 6,95k | 0,00 | Derivative Exercise and Retained Stock | - | 103,99k | 7,16% |
| 2026-03-15 | Mr. Tarkan ManerPresident & Chief Commercial Officer | -4,09k | 160,81k | Derivative Exercise and Sale | 39,29 | 103,99k | - |
| 2026-03-15 | Mr. Brian Michael MartinChief Legal Officer | 2,91k | 0,00 | Derivative Exercise and Retained Stock | - | 10,40k | 38,83% |
| 2026-03-15 | Mr. Brian Michael MartinChief Legal Officer | -1,82k | 71,47k | Derivative Exercise and Sale | 39,29 | 10,40k | - |
| 2026-03-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | 14,09k | 0,00 | Derivative Exercise and Retained Stock | - | 279,62k | 5,30% |
| 2026-03-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -8,06k | 316,83k | Derivative Exercise and Sale | 39,29 | 279,62k | - |
| 2025-12-15 | Dr. Rajiv RamaswamiCEO & Director | 23,27k | 0,00 | Derivative Exercise and Retained Stock | - | 547,88k | 4,44% |
| 2025-12-15 | Dr. Rajiv RamaswamiCEO & Director | -27,16k | 1,30M | Derivative Exercise and Sale | 47,76 | 547,88k | - |
| 2025-12-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | 10,90k | 0,00 | Derivative Exercise and Retained Stock | - | 265,54k | 4,28% |
| 2025-12-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -11,25k | 537,25k | Derivative Exercise and Sale | 47,76 | 265,54k | - |
| 2025-12-15 | Mr. Brian Michael MartinChief Legal Officer | 2,32k | 0,00 | Derivative Exercise and Retained Stock | - | 7,49k | 44,99% |
| 2025-12-15 | Mr. Brian Michael MartinChief Legal Officer | -2,40k | 114,67k | Derivative Exercise and Sale | 47,76 | 7,49k | - |
| 2025-10-02 | Dr. Rajiv RamaswamiCEO & Director | -144,71k | 11,06M | Automatic Disposition | 76,26 - 76,87 | 524,61k | -21,62% |
| 2025-10-02 | Ms. Gayle SheppardIndependent Director | -3,50k | 267,69k | Automatic Disposition | 76,40 - 76,88 | 18,75k | -15,73% |
| 2025-09-30 | Mr. Brian Michael MartinChief Legal Officer | -10,24k | 783,73k | Automatic Disposition | 76,53 | 5,17k | -66,47% |
| 2025-09-15 | Mr. Brian Michael MartinChief Legal Officer | -11,30k | 883,77k | Derivative Exercise and Sale | 78,21 | 15,18k | - |
| 2025-09-15 | Mr. Brian Michael MartinChief Legal Officer | -203,00 | 15,88k | Sale to Issuer | 78,21 | 15,18k | -1,32% |
| 2025-09-15 | Dr. Rajiv RamaswamiCEO & Director | -50,23k | 3,93M | Derivative Exercise and Sale | 78,21 | 669,23k | - |
| 2025-09-15 | Dr. Rajiv RamaswamiCEO & Director | -125,59k | 9,82M | Sale to Issuer | 78,21 | 669,23k | -15,80% |
| 2025-09-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -21,34k | 1,67M | Derivative Exercise and Sale | 78,21 | 254,64k | - |
| 2025-09-16 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -11,39k | 892,41k | Automatic Disposition | 78,34 | 254,64k | -4,28% |
| 2025-09-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -37,43k | 2,93M | Sale to Issuer | 78,21 | 254,64k | -12,81% |
| 2025-06-26 | Dr. Rajiv RamaswamiCEO & Director | -1,93k | 144,38k | Automatic Disposition | 75,00 | 518,56k | -0,37% |
| 2025-06-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | 8,40k | 0,00 | Derivative Exercise and Retained Stock | - | 209,07k | 4,19% |
| 2025-06-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -12,94k | 934,63k | Derivative Exercise and Sale | 72,13 - 73,25 | 209,07k | - |
| 2025-06-15 | Dr. Rajiv RamaswamiCEO & Director | 23,18k | 0,00 | Derivative Exercise and Retained Stock | - | 520,49k | 4,66% |
| 2025-06-15 | Dr. Rajiv RamaswamiCEO & Director | -27,05k | 1,95M | Derivative Exercise and Sale | 72,13 | 520,49k | - |
| 2025-06-05 | Ms. Virginia GambaleIndependent Chairman | -7,00k | 546,00k | Vente | 78,00 | 38,33k | -15,44% |
| 2025-06-05 | Bain Capital, LPSociété | -5,48M | 420,95M | Vente | 76,81 | 5,36M | -50,58% |
| 2025-06-05 | Bain Capital, LPSociété | -125,18k | 0,00 | Other Disposition | - | 5,36M | -2,28% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
